Home/Filings/4/0001104659-22-069009
4//SEC Filing

Coiante Scott M 4

Accession 0001104659-22-069009

CIK 0001781983other

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 5:02 PM ET

Size

4.6 KB

Accession

0001104659-22-069009

Insider Transaction Report

Form 4
Period: 2022-06-03
Coiante Scott M
SVP, Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock

    2022-06-03$0.81/sh35,284$28,40484,265 total
Footnotes (1)
  • [F1]Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 86,067 restricted stock units.

Issuer

Aprea Therapeutics, Inc.

CIK 0001781983

Entity typeother

Related Parties

1
  • filerCIK 0001608536

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 5:02 PM ET
Size
4.6 KB